News

Endovascular Today13d
Cordis Selution SLR DEB Evaluated in Two Studies of Complex PAD Patients
Cordis announced new data from the SUCCESS PTA and SELUTION SFA Japan peripheral studies evaluating the company’s Selution ...
Seeking Alpha13d
Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR™ Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients
These results demonstrate that SELUTION SLR™ DEB is the only drug-eluting technology with core-lab adjudicated 3-year patency over 80%. "SELUTION SLR™ DEB represents the next evolution in ...